Carl Goldfischer, Director at CymaBay Therapeutics, Inc. (CBAY), sold 23,350 shares at $9.02 ($211K) on 2019-02-07, disclosed to the SEC on 2019-02-08.
Open-market sale of $211k CBAY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.02 | 11,675 | $105K | 50.0% |
| 2 | $9.02 | 11,675 | $105K | 50.0% |
| Total | $9.02 avg | 23,350 | $211K | 100% |
| Filing → |
| CBAY | SELL | 2017-11-06 | $156K | — | Filing → |
| ETRM | SELL | 2017-05-31 | $23K | — | Filing → |
| EPZM | BUY | 2016-01-12 | $5.0M | — | Filing → |